Endovascular therapy in the distal neurovascular territory: results of a large prospective registry
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
33323503
DOI
10.1136/neurintsurg-2020-016851
PII: neurintsurg-2020-016851
Knihovny.cz E-zdroje
- Klíčová slova
- stroke, thrombectomy,
- MeSH
- cévní mozková příhoda * diagnostické zobrazování chirurgie MeSH
- endovaskulární výkony * MeSH
- lidé MeSH
- registrace MeSH
- trombektomie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: There is a paucity of data regarding mechanical thrombectomy (MT) in distal arterial occlusions (DAO). We aim to evaluate the safety and efficacy of MT in patients with DAO and compare their outcomes with proximal arterial occlusion (PAO) strokes. METHODS: The Trevo Registry was a prospective open-label MT registry including 2008 patients from 76 sites across 12 countries. Patients were categorized into: PAO: intracranial ICA, and MCA-M1; and DAO: MCA-M2, MCA-M3, ACA, and PCA. Baseline and outcome variables were compared across the PAO vs DAO patients with pre-morbid mRS 0-2. RESULTS: Among 407 DAOs including 350 (86.0%) M2, 25 (6.1%) M3, 10 (2.5%) ACA, and 22 (5.4%) PCA occlusions, there were 376 DAO with pre-morbid mRS 0-2 which were compared with 1268 PAO patients. The median baseline NIHSS score was lower in DAO (13 [8-18] vs 16 [12-20], P<0.001). There were no differences in terms of age, sex, IV-tPA use, co-morbidities, or time to treatment across DAO vs PAO. The rates of post-procedure reperfusion, symptomatic intracranial hemorrhage (sICH), and 90-mortality were comparable between both groups. DAO showed significantly higher rates of 90-day mRS 0-2 (68.3% vs 56.5%, P<0.001). After adjustment for potential confounders, the level of arterial occlusion was not associated with the chances of excellent outcome (DAO for 90-day mRS 0-1: OR; 1.18, 95% CI [0.90 to 1.54], P=0.225), successful reperfusion or SICH. However, DAO patients were more likely to be functionally independent (mRS 0-2: OR; 1.45, 95% CI [1,09 to 1.92], P=0.01) or dead (OR; 1.54, 95% CI [1.06 to 2.27], P=0.02) at 90 days. CONCLUSION: Endovascular therapy in DAO appears to result in a comparable safety and technical success profile as in PAO. The potential benefits of DAO thrombectomy should be investigated in future randomized trials.
Advocate Neurovascular Center Advocate Health Care Library Network Park Ridge Illinois USA
Department of Neurology California Pacific Medical Center San Francisco California USA
Department of Neurology UCLA Los Angeles California USA
Department of Neurology Vascular Neurology of Southern California Thousand Oaks California USA
Department of Neuroradiology CHUV Lausanne VD Switzerland
Department of Neuroradiology Riverside Methodist Hospital Columbus Ohio USA
Department of Neuroradiology University Hospital Hradec Kralove Hradec Kralove Czech Republic
Department of Neurosciences Drexel University College of Medicine Philadelphia Pennsylvania USA
Department of Neurosciences WellStar Health System Atlanta Georgia USA
Department of Radiology University of Maryland School of Medicine Baltimore Maryland USA
Department of Radiology University of Tennessee Chattanooga TN USA
Division of Biostatistics Stryker Neurovascular Fremont California USA
Neurology University of Texas McGovern Medical School Houston Texas USA
Citace poskytuje Crossref.org